Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial - American Journal of Kidney Diseases
Issues · localForage/localForage · GitHub
Joining failed - Connection Timeout - General Discussion - ARK - Official Community Forums